Applying this framework to human brain, liver, and testis promoters, we identified and validated clinically relevant transcription factors (TFs) in the brain, including SP1, MYC, and HES6, and confirmed their known roles in diseases such as gliomas and neuroblastomas. This evidence concerns the gene HES6 and neuroblastoma.